Myocarditis Caused by COVID-19: A Case Report and Literature Review
Published: 2023-06-12
Page: 213-216
Issue: 2023 - Volume 6 [Issue 1]
Mohammed Nachid *
Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.
Karim Mounaouir
Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.
Ali El Jazouli
Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.
Meryem Haboub
Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.
Bennouna Ghali
Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.
Arous Salim
Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.
Abdenasser Drighil
Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.
Rachida Habbal
Cardiology Division, Ibn Rochd University Hospital, Casablanca-20250, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Myocarditis, an inflammatory disease of the myocardium, has been identified as a potential complication of COVID-19. Here we present a case report of a 45-year-old male patient who was diagnosed with myocarditis following a COVID-19 infection. The patient presented with chest pain, dyspnea, and palpitations. ECG and cardiac MRI revealed findings consistent with myocarditis. The patient was treated with anti-inflammatory medication and recovered with no residual cardiac dysfunction. The case highlights the potential for COVID-19 to cause myocarditis and the importance of prompt diagnosis and management in these patients.
Keywords: Myocarditis, COVID-19, diagnosis, cardiac MRI, immunomodulatory agents, complications